Contralateral prophylactic mastectomy in an Asian population: A single institution review

Breast

Volumn 23, Issue 1, 2014, Pages 56-62

  Sim, Yirong ^a   Tan, Veronique Kiak Mien ^b   Ho, Gay Hui ^b   Wong, Chow Yin ^a   Madhukumar, Preetha ^b   Tan, Benita Kiat Tee ^a   Yong, Wei Sean ^b   Ng, Yvonne Ying Ru ^c   Ong, Kong Wee ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

BCS; Bilateral breast carcinoma; CBC; Contralateral breast cancer Asia; Contralateral prophylactic mastectomy; CPM; ER; MRI; PR; Prophylactic mastectomy

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASIAN; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CONTRALATERAL PROPHYLACTIC MASTECTOMY; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MARRIED PERSON; MASTECTOMY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NULLIPARA; PARTIAL MASTECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGAPORE; SURGICAL RISK;

BCS; BILATERAL BREAST CARCINOMA; BREAST CONSERVING SURGERY; CBC; CONTRALATERAL BREAST CANCER; CONTRALATERAL BREAST CANCER ASIA; CONTRALATERAL PROPHYLACTIC MASTECTOMY; CPM; ER; MAGNETIC RESONANCE IMAGING; MRI; OESTROGEN RECEPTOR; PR; PROGESTERONE RECEPTOR; PROPHYLACTIC MASTECTOMY;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; COHORT STUDIES; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SINGAPORE;

EID: 84890884476     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.10.008     Document Type: Article

References (46)

1. Herrinton L.J., Barlow W.E., Yu O., Geiger A.M., Elmore J.G., Barton M.B., et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol 2005, 23:4275-4286.
2. Robbins G.F., Berg J.W. Bilateral primary breast cancer, a prospective clinicopathological study. Cancer 1964, 17:1501-1527.
3. Chaudary M.A., Millis R.R., Hoskins E.O., Halder M., Bulbrook R.D., Cuzick J., et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 1984, 71:711-714.
4. Rosen P.P., Groshen S., Kinne D.W., Hellman S. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1-N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery 1989, 106:904-910.
5. Aisenberg A.C., Finkelstein D.M., Doppke K.P., Koerner F.C., Boivin J.-F., Willet C.G. High risk of breast carcinoma after irradiation of yound women with Hodgkin's disease. Cancer 1997, 79:1203-1210.
6. Van Sprundel T.C., Schmidt M.K., Rookus M.A., Brohet R., van Asperen C.J., Rutgers E.J., et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. Br J Cancer 2005, 93:287-292.
7. McDonnell S.K., Schaid D.J., Myers J.L., Grant C.S., Donohue J.H., Woods J.E., et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 2001, 19:3938-3943.
8. Carter C.L., Allen C., Henson D.E. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989, 63:181-187.
9. Damle S., Teal C.B., Lenert J.J., Marshall E.C., Pan Q., McSwain A.P. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review. Ann Surg Oncol 2010, 18:1356-1363.
10. Lostumbo L., Carbine N., Wallace J., Ezzo J. Prophylactic mastectomy for prevention of breast cancer. Cochrane Database Syst Rev 2004, 4. CD002748.
11. Jones N.B., Wilson J., Kotur L., Stephens J., Farrar W.B., Agnese D.M. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol 2009, 16:2691-2696.
12. Arrington A.K., Jarosek S.L., Virnig B.A., Habermann E.B., Tuttle T.M. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 2009, 16:2697-2704.
13. Alderman A.K., Hawley S.T., Waljee J., Morrow M., Katz S.J. Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction. Cancer 2007, 109:1715-1720.
14. Peralta E.A., Ellenhorn J.D., Wagman L.D., Dagis A., Andersen J.S., Chu D.Z. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 2000, 180:439-445.
15. Pathy N.B., Yip C.H., Taib N.A., Hartman M., Saxena N., Iau P., et al. Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry. Breast 2011, 20:S75-S80.
16. Smigal C., Jemal A., Ward E., Cokkinides V., Smith R., Howe H.L., et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 2006, 56:168-183.
17. Miller B.A., Hankey B.F., Thomas T.L. Impact of sociodemographic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 2002, 155:534-545.
18. Agarwal G., Pradeep P.V., Aggarwal V., Yip C.H. Spectrum of breast cancer in Asian women. World J Surg 2007, 31:1031-1040.
19. Chen Z., Wu A.H., Gauderman W.J., Bernstein L., Ma H., Pike M.C., et al. Does mammographic density reflect ethnic diferences in breast cancer incidence rates?. Am J Epidemiol 2004, 159:140-147.
20. Leong B.D.K., Chuah J.A., Kumar V.M., Rohamini S., Siti Z.S., Yip C.H. Trends of breast cancer treatment in Sabah, Malaysia: a problem with lack of awareness. Singapore Med J 2009, 50:772-776.
21. Kirby R.M., Basit A., Manimaran N. Patient choice significantly affects mastectomy rates in the treatment of breast cancer. Int Semin Surg Oncol 2008, 5:20.
22. Katz S.J., Lantz P.M., Janz N.K., Fagerlin A., Schwartz K., Liu L., et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol 2005, 23:5526-5533.
23. Key demographic trends 2010, http://wwwsingstatgovsg/publications/publications_and_papers/cop2010/census_2010_advance_census_release/key_demographic_trends.pdf.
24. Jara-Lazaro A.R., Thilagaratnam S., Tan P.H. Breast cancer in Singapore: some perspectives. Breast Cancer 2010, 17:23-28.
25. Sim X., Ali R.A., Wedren S., Goh D.L., Tan C.-S., Reilly M., et al. Ethnic differences in the time trend of female breast cancer incidence: Singapore. BMC Cancer 1968-2002, 2006(6):261.
26. Chia K.S., Lee J.J.M., Wong J.L.L., Gao W., Lee H.P., Shanmugaratnam K. Cancer incidence in Singapore, 1998 to 1999. Ann Acad Med Singapore 2002, 31:745-750.
27. Sant M., Allemani C., Berrino F., Coleman M.P., Aareleid T., Chaplain G., et al. Breast carcinoma survival in Europe and the United States. Cancer 2004, 100:715-722.
28. Tuttle T.M., Habermann E.B., Grund E.H., Morris T.J., Virnig B.A. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 2007, 25:5203-5209.
29. Wang J., Kollias J., Boult M., Babidge W., Zobas H.N., Roder D., et al. Patterns of surgical treatment for women with breast cancer in relation to age. Breast J 2010, 16:60-65.
30. Dellapasqua S., Colleoni M., Castiglione M., Goldhirsch A. New criteria for selecting elderly patients for breast cancer adjuvant treatment studies. Oncologist 2007, 12:952-959.
31. Kiderlen M., Bastiaannet E., Walsh P.M., Keating N.L., Schrodi S., Engel J., et al. Surgical treatment of early stage breast cancer in elderly: an international comparison. Breast Cancer Res Treat 2012, 132:675-682.
32. Stucky C.-C.H., Gray R.J., Wasif N., Dueck A.C., Pockaj B.A. Increase in contralateral prophylactic mastectomy: echoes of a bygone era?. Ann Surg Oncol 2010, 17:S330-S337.
33. Howard-McNatt M., Schroll R.W., Hurt G.J., Levine E.A. Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations. Am J Surg 2011, 202:298-302.
34. Schwartz M.D., Hughes C., Roth J., Main D., Peshkin B.N., Isaacs C., et al. Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol Biomarkers Prev: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 2000, 9:381-385.
35. van Geel A.N. Prophylactic mastectomy: the Rotterdam experience. Breast 2003, 12:357-361.
36. Fang S.Y., Balneaves L.G., Shu B.C. "A struggle between vanity and life": the experience of receiving breast reconstruction in women of Taiwan. Cancer Nurs 2010, 33:E1-E11.
37. Barry P.N., Johnson R.R., Harkenrider M.M., Freeman A.B., Kruse B., Wilson M.R., et al. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database. Am J Med Sci 2012, 344(6):452-456.
38. Goldflam K., Hunt K.K., Gershenwald J.E., Singletary S.E., Mirza N., Kuerer H.M., et al. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 2004, 101:1977-1986.
39. King T.A., Gurevich I., Sakr R., Patil S., Stempel M., Morrow M. Occult malignancy in patients undergonig contralateral prophylactic mastectomy. Ann Surg 2011, 254:2-7.
40. King T.A., Sakr R., Patil S., Gurevich I., Stempel M., Sampson M., et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy 2011, 29:2158-2164.
41. del Carmen M.G., Haplern E.G., Kopans D.B., Mov B., Moore R.H., Goss P.E., et al. Mammographic breast density and race. AJR Am K Roentgenol 2007, 188:1147-1150.
42. Wee S.B. The case for breast cancer screening in Singapore. Singapore Med J 2002, 43:221-223.
43. Muttarak M., Pojchamarnwiputh S., Chaiwun B. Breast carcinomas: why are they missed?. Singapore Med J 2006, 47:851-857.
44. Leung T.-K., Huang P.-J., Chen C.-S., Lin Y.-H., Wu C.-H., Lee C.-M. Is breast MRI screening more effective than digital mammography in Asian women?. J Exp Clin Med 2010, 2:245-250.
45. Leong S.P., Shen Z.Z., Tiu T.J., Agarwal G., Tajima T., Paik N.S., et al. Is breast cancer the same disease in Asian and Western countries?. World J Surg 2010, 34:2308-2324.
46. Kaplan H.G., Malmgren J.A. The breast cancer overdiagnosis conundrum: an oncologist's viewpoint. Ann Intern Med 2013, 158:60-61.